VEGFR2 and hepatocellular carcinoma inhibitory activities of trisubstituted triazole derivatives
Amani M.R. Alsaedi, Samar J. Almehmadi, Thoraya A. Farghaly, Marwa F. Harras, Khaled D. Khalil
Topics & Concepts
ChemistrySorafenibADMETriazoleBioavailabilityDocking (animal)IC50In silicoIn vitroHepatocellular carcinomaStereochemistryLead compoundPharmacologyCombinatorial chemistryBiochemistryCancer researchOrganic chemistryMedicineBiologyNursingGeneClick Chemistry and ApplicationsCancer Mechanisms and TherapyPeptidase Inhibition and Analysis